Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 100 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7618936

    Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)

    The Regents of the University of California · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  2. US 7615573

    Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted
  3. US 7612091

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  4. US 7612065

    Inhibitors of c-JUN N-terminal kinases (JNK)

    Vertex Pharmaceuticals Incorporated · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  5. US 7608632

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  6. US 7608422

    Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted
  7. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  8. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  9. US 7601718

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  10. US 7601713

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  11. US 7598245

    Aminotriazole compounds useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  12. US 7598277

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  13. US 7595326

    Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs

    Champions Biotechnology, Inc · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted
  14. US 7592340

    Quinoxalines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  15. US 7592368

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  16. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  17. US 7589220

    Inhibitors of the anandamide transporter

    UNIVERSITY OF CONNECTICUT · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  18. US 7589214

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  19. US 7585842

    Human kunitz-type inhibitor with enhanced antifibrinolytic activity

    The Regents of the University of California · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  20. US 7585844

    Myosin light chain kinase inhibitors and methods of use

    University College Cardiff Consultants Limited · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  21. US 7582605

    Phosphorus-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  22. US 7582662

    Body weight gain inhibitor

    Takeda Pharmaceutical Company Limited · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  23. US 7582676

    2-phenylpyran-4-one derivatives as selective COX-2 inhibitors

    Laboratories Almirall, S.A. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  24. US 7582641

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted